Advances in Studies Related to Interleukin-12 Family and Infectious Diseases

Open access

Abstract

Interleukin (IL)-12 family is a group of cytokines composed of heterogeneous molecules and whose members include IL-12, IL-23, IL-27, and IL-35. IL-12 family bridges natural and adaptive immune responses and especially plays a significant role in classical adaptive immune process participated by TH1, TH17, and Treg cells. Members of IL-12 family participate in adaptive immune responses via the Janus kinase-signal transducers and activators of transcription signaling pathway by sharing some subunits and receptors. IL-12 features an extremely complex regulatory network. During resistance of microbial infection, IL-12 and IL-23 mainly show inflammatory effects, whereas IL-27 and IL-35 commonly show antiinflammatory effects. This study reviews advances in studies related to IL-12 family members and infectious diseases and provides references to further reveal functions of IL-12 family members in occurrence and development of infectious diseases.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1 Kalliolias GD1 Ivashkiv LB. IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J Immunol 2008 180(9): 6325-6333.

  • 2 Gee K Guzzo C Che Mat NF et al. The IL-12 family of cytokines in infection inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 20098(1):40-52.

  • 3 Shimizu J Kaneko F Suzuki N. Skewed helper T-cell responses to IL-12 family cytokines produced by antigen-presenting cells and the genetic background in Behcet’ s disease. Genet Res Int 2013 2013:363859.

  • 4 Yuzhalin AE1 Kutikhin AG. Interleukin-12: clinical usage and molecular markers of cancer susceptibility. Growth Factors 2012 30(3):176-191.

  • 5 Friedmann E1 Hauben E Maylandt K et al. SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production. Nat Cell Biol 20068 (8): 843-848.

  • 6 Banerjee S Halder K Bose A et al. TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophages. Carcinogenesis 2012 32(12): 1789-1797.

  • 7 Ko SY Ladanyi A Lengyel E et al. Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype. Am J Pathol 2014 184(1):271-281.

  • 8 Clerici M Saresella M Trabattoni D. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J Neuroimmunol 2001 121(1-2):88-101.

  • 9 Naderi M Saeedi A Moradi A et al. Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity. Virol Sin 201328(3): 167-173.

  • 10 Metzger DW. Interleukin-12 as an adjuvant for induction of protective antibody responses. Cytokine 2010 52(1-2):102-107.

  • 11 Wei F Wang H Zhang J et al. Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12. J Exp Clin Cancer Res 201332:5.

  • 12 Saghafian-Hedengren S Sohlberg E Theorell J et al. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J Virol 201387 (24):13446-13455.

  • 13 Kita Y Hashimoto S Nakajima T et al. Novel therapeutic vaccines[(HSP65 + IL-12)DNA- granulysin-and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy. Hum Vaccin Immunother 20129(3):526-533.

  • 14 Schurich A Pallett LJ Lubowiecki M et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog 20139(3): e1003208.

  • 15 Pauls E Jimenez E Ruiz A et al. Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1. J Immunol 2013190(9): 4736-4741.

  • 16 Ricardo-Carter C Favila M Polando RE et al. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription. Parasite Immunol 201335(12):409-420.

  • 17 Hugentobler F Yam K K Gillard J et al. Immunization against Leishmania major infection using LACK-and IL-12 - expressing Lactococcus lactis induces delay in footpad swelling. PLoS One 20127(2):e30945.

  • 18 Oppmann B Lesley R Blom B et al. Novel p19 protein engages IL-12p40 to form a cytokine IL-23 with biological activities similar as well as distinct from IL-12. Immunity 200013 (5):715-725.

  • 19 Chognard G Bellemare L Pelletier AN et al. The dichotomous pattern of IL-12R and IL-23R expression elucidates the role of IL-12 and IL-23 in inflammation. PLoS One 20149(2):e89092.

  • 20 Boniface K Blom B Liu YJ et al. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev 2008226:132-146.

  • 21 De Simone V Pallone F Monteleone G et al. Role of TH17 cytokines in the control of colorectal cancer. Oncoimmunology 20132(12): e26617.

  • 22 Kagami S Rizzo HL Kurtz SE et al. IL-23 and IL-17A but not IL-12 and IL-22 are required for optimal skin host defense against Candida albicans. J Immunol 2010 185(9):5453-5462.

  • 23 Verreck FA de Boer T Langenberg DM. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria. PNAS 2004101(13): 4560-4565.

  • 24 Rudner XL Happel KI Young EA et al. Interleukin-23(IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 200775(6):3055-3061.

  • 25 Palma C Schiavoni G Abalsamo L et al. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4 + T cells via dendritic cell activation. Eur J Immunol 201343(9):2386-2397.

  • 26 Wang JM Ma CJ Li GY et al. Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection. Vaccine 201331(18):2238-2245.

  • 27 Ishida H Imai T Suzue K et al. IL-23 protection against Plasmodium berghei infection in mice is partially dependent on IL-17 from macrophages. Eur J Immunol 201343(10):2696-2706.

  • 28 Pflanz S Hibbert L Mattson J et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004172(4): 2225-2231.

  • 29 Villegas-Mendez A de Souza JB Lavelle SW et al. IL-27 receptor signalling restricts the formation of pathogenic terminally differentiated TH1 cells during malaria infection by repressing IL-12 dependent signals. PLoS Pathog 20139(4):e1003293.

  • 30 Zhang GL Xie DY Ye YN et al. High level of IL-27 positively correlated with TH17 cells may indicate liver injury in patients infected with HBV. Liver Int 201434(2):266-273.

  • 31 Cao J Zhang L Li D et al. IL-27 is elevated in patients with COPD and patients with pulmonary TB and induces human bronchial epithelial cells to produce CXCL10. Chest 2012141 (1): 121-130.

  • 32 Chen Q Swaminathan S Yang D et al. Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway. PLoS One 2013 8(3):e59194.

  • 33 Collison LW Workman CJ Kuo TT et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450(7169):566-569.

  • 34 Bardel E Larousserie F Charlot-Rabiega P et al. Human CD4 +CD25+Foxp3 + regulatory T cells do not constitutively express IL-35. J Immunol 2008181(10):6898-6905.

  • 35 Shen P Roch T Lampropoulou V et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014 doi: 10.1038/nature12979.

  • 36 Collison LW Chaturvedi V Henderson AL et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 201011(12):1093-1101.

  • 37 Long J Zhang X Wen M et al. IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun 2013430(1):364-369.

  • 38 Wang Z Liu JQ Liu Z. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol 2013190(5): 2415-2423.

  • 39 Zeng JC Zhang Z Li TY et al. Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int J Clin Exp Pathol 20136(9):1806-1816.

  • 40 Xie Y Chen R Zhang X et al. The role of TH17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis. Virology 2011 421(1):78-84.

Search
Journal information
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 206 90 6
PDF Downloads 78 42 2